# A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder

> **NCT01034995** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 580 (estimated)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** SSR125543
- **DRUG:** escitalopram
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01034995
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 580 (ESTIMATED)
- **Last updated:** 2011-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034995, "A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01034995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*